| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/10/2005 | US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 05/10/2005 | US6890914 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 05/10/2005 | US6890897 In combination with an osteoinductive protein and a bone morphogenetic protein or a hedgehog protein to induce osteogenesis; biocompatible or biodegradable matrix |
| 05/10/2005 | US6890728 Recovering cell components from sample; obtain cells sample, lyse, centrifuge, withdraw fluid, detect cell components |
| 05/10/2005 | CA2303801C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 05/10/2005 | CA2250569C Novel phenanthridines substituted in the 6 position |
| 05/10/2005 | CA2191815C Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use |
| 05/10/2005 | CA2123579C Recombinant multivalent m protein vaccine |
| 05/06/2005 | WO2005040172A1 Tricyclic proline derivative |
| 05/06/2005 | WO2005040148A1 New rar$g(b) receptor-activating ligand, method for the preparation thereof and use thereof in human medicine and in cosmetics |
| 05/06/2005 | WO2005039607A1 The use of balloonfish collagen i extractive in medical care and the preparative method of it |
| 05/06/2005 | WO2005039602A1 Pharmacologically functional water and use thereof |
| 05/06/2005 | WO2005039599A1 Matrix metalloprotease inhibitor containing polylactic acid mixture |
| 05/06/2005 | WO2005039583A1 METHOD OF TREATING RHEUMATOID ARTHRITIS USING NF-kB INHIBITORS |
| 05/06/2005 | WO2005039577A1 Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain |
| 05/06/2005 | WO2005039576A1 Combinations of potassium channel openers and sodium channel inhibitors or active substances influencing sodium channels in order to treat painful conditions |
| 05/06/2005 | WO2003068746A8 Aryl ureas as kinase inhibitors |
| 05/06/2005 | WO2003068146A3 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/06/2005 | WO2003010286A3 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 05/06/2005 | CA2542434A1 Combination of flupirtine and tolperisone or eperisone for the treatment of painful conditions |
| 05/06/2005 | CA2539193A1 New rarbeta receptor-activating ligand, method for the preparation ther eof and use thereof in human medicine and in cosmetics |
| 05/05/2005 | US20050096479 Novel succinate salt of O-desmethyl-venlafaxine |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096363 Activator of peroxisome proliferator-activated receptor delta |
| 05/05/2005 | US20050096356 2-[[6-Methoxy-3-pyridinyl]methyl]amino-N-[3-(trifluoromethyl)phenyl]benzamide hydrochloride salt or its tautomer; treating retinopathy or age-related macula degeneration |
| 05/05/2005 | US20050096331 Alkyl carboxylic acids and their derivatives; antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds; better efficacy, potency and lower toxicity |
| 05/05/2005 | US20050096322 Nitrogen-containing heterocyclic compound |
| 05/05/2005 | US20050096321 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
| 05/05/2005 | US20050096313 Substance P; 2-(phenyl)-4-(3-oxo-piperazin-1-yl-)-piperidine-1-carboxylic acid; benzyl-methylamide; antagonists of the NK1 receptor; antidepressant, antiolytic; antiemetic |
| 05/05/2005 | US20050096285 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 05/05/2005 | US20050096271 Fusion of polypeptides and immunoglobulin protein; immunotherapy ; antiallergens; antiarthritic agents; anticancer agents; antiinflammatory agents |
| 05/05/2005 | US20050096268 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 05/05/2005 | US20050096256 Compositions for manipulating the lifespan and stress response of cells and organisms |
| 05/05/2005 | US20050095234 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5 |
| 05/04/2005 | EP1528103A1 'Osteoclast-inhibitory factor' (OCIF) derived proteins and methods for producing the proteins |
| 05/04/2005 | EP1528058A1 Polymorphic crystalline forms of celecoxib |
| 05/04/2005 | EP1527343A2 Organic compounds |
| 05/04/2005 | EP1527171A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 05/04/2005 | EP1527076A1 Dihydro-dibenzo (b,e) oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/04/2005 | EP1527074A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/04/2005 | EP1527070A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators |
| 05/04/2005 | EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 05/04/2005 | EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 05/04/2005 | EP1527046A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |
| 05/04/2005 | EP1526895A2 Methods for treating carbonic anhydrase mediated disorders |
| 05/04/2005 | EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 05/04/2005 | EP1526862A1 Simmondsin for use as an angiogenesis inhibitor |
| 05/04/2005 | EP1526860A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 05/04/2005 | EP1526859A1 Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 05/04/2005 | EP1526852A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/04/2005 | EP1526847A2 Pharmaceutical dosage form comprising a sulfite compound |
| 05/04/2005 | EP1526846A2 Gelatin capsule exhibiting reduced cross-linking |
| 05/04/2005 | EP1526845A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 05/04/2005 | EP1526844A2 Pellicle-resistant gelatin capsule |
| 05/04/2005 | EP1395582B1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/04/2005 | EP1362062B1 Concatameric immunoadhesion |
| 05/04/2005 | EP1362048B1 Triazolo compounds as mmp inhibitors |
| 05/04/2005 | EP1341539B1 Anti-inflammatory agents |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP1255546B1 Method for improving bone modeling and chondrocyte functioning in growing canines |
| 05/04/2005 | EP1240165B1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 05/04/2005 | EP1180519B1 Hydrochloride of fused-heterocycle compound |
| 05/04/2005 | EP1124810B1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/04/2005 | CN1612893A VEGF peptides and their use for inhibiting angiogenesis |
| 05/04/2005 | CN1612865A Triazole derivatives as cyclooxygenase (COX) inhibitors |
| 05/04/2005 | CN1612863A Deuterated substituted pyrazolylbenzylsulfonamides pharmaceutical compositions containing them and use thereof |
| 05/04/2005 | CN1612852A Lipoxin A4 analogs |
| 05/04/2005 | CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 05/04/2005 | CN1612739A Method for treating or preventing inflammatory diseases |
| 05/04/2005 | CN1612731A Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases |
| 05/04/2005 | CN1612729A 2-aryl-propionic acid and medicine composition containing same |
| 05/04/2005 | CN1612715A Method, instruments, and kit for autologous transplantation |
| 05/04/2005 | CN1611499A Heterocyclic compounds as inhibitors of rotamase enzymes |
| 05/04/2005 | CN1611253A Medicine for treating lumbosacral pain and its preparing method |
| 05/04/2005 | CN1611242A Bone-healing medicine |
| 05/04/2005 | CN1611237A Musk tendon relaxation and joint rigidity relieving medicine |
| 05/04/2005 | CN1611223A Sulfony lated acetylglucosamine medicinal composition and its use |
| 05/04/2005 | CN1611213A Novel 13 uses of neoarsphenamine |
| 05/04/2005 | CN1200000C Cyclie somatostatin analogs |
| 05/04/2005 | CN1199971C Quaternary ammonium compounds as tachykinin antagonists |
| 05/04/2005 | CN1199950C Quinolene derivatives as anti-inflammation agents |
| 05/04/2005 | CN1199648C Application of sophoricoside |
| 05/04/2005 | CN1199636C Use of 15-deoxysperguallin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 05/03/2005 | US6888004 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/03/2005 | US6887996 Compounds and their use |
| 05/03/2005 | US6887892 Tricyclic derivatives of indole with antiangiogenic activity |
| 05/03/2005 | US6887883 Combating angiogenic activity in a human comprising administering to a chrysanthone compound |
| 05/03/2005 | US6887874 For producing an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal; therapy of cancer, rheumatoid arthritis |
| 05/03/2005 | US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 04/28/2005 | WO2005037814A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 04/28/2005 | WO2005036989A1 Health food containing hyaluronic acid and dermatan sulfate |
| 04/28/2005 | WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 04/28/2005 | US20050090547 Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
| 04/28/2005 | US20050090536 Substituted pyrrol-3-ylisoxazoles, e.g., N-benzyl-4-[4-(o-chlorophenyl)-5-isoxazolyl)pyrrole-2-carboxamide; treating diseases that are alleviated by a protein kinase inhibitor, particularly cancer, inflammatory disorders, restenosis, and cardiovascular disease. |